Pancreatic Cancer Research

ResearcherSHOWA Medical UniversityActive in the last 2 years

Ken-Ichi Fujita

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1575-6690; OpenAlex author ID A5101528279. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Association Between ABCC2 -24C>T and Nab-Paclitaxel-induced Peripheral Neuropathy in Japanese Patients With Pancreatic Cancer. Last author DOI 10.21873/anticanres.17326↗
  2. Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunction. Co-author DOI 10.1111/cas.12851↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hitoshi Yoshida · 1 shared paper, 2024 · strength 0.16
  2. Shu Oikawa · 1 shared paper, 2024 · strength 0.16
  3. Hana Nakayama · 1 shared paper, 2024 · strength 0.16
  4. Yukio Ando · 1 shared paper, 2016 · strength 0.06
  5. Masato Nagino · 1 shared paper, 2016 · strength 0.06
  6. Takashi Shibata · 1 shared paper, 2016 · strength 0.06
  7. Yasutsuna Sasaki · 1 shared paper, 2016 · strength 0.06
  8. Osamu Maeda · 1 shared paper, 2016 · strength 0.06
  9. Tomoki Ebata · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.